Thymosin Alpha-1

Thymosin Alpha-1 (Tα1) is a naturally occurring 28-amino acid peptide originally isolated from thymic tissue that plays a central role in immune system function and maturation. The synthetic version (Zadaxin) is approved in over 35 countries for treatment of hepatitis B, hepatitis C, and as an immune adjuvant in cancer therapy and vaccination. Research demonstrates Tα1 enhances T-cell differentiation and function, augments natural killer cell activity, promotes dendritic cell maturation, and modulates cytokine production. The peptide restores immune function in immunocompromised states and has shown efficacy as an adjunct therapy in various cancers and chronic infections. Studies indicate potential benefits for sepsis, immunodeficiency, and age-related immune decline. Tα1 acts through Toll-like receptors and enhances both innate and adaptive immune responses without overstimulation. Clinical applications include improving response to vaccines in immunocompromised patients and supporting immune reconstitution. The peptide is generally well-tolerated with minimal side effects.